Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 17.46
ICAD's Cash to Debt is ranked higher than
52% of the 1865 Companies
in the Global Software - Application industry.

( Industry Median: 11.22 vs. ICAD: 17.46 )
Ranked among companies with meaningful Cash to Debt only.
ICAD' s Cash to Debt Range Over the Past 10 Years
Min: 0.04  Med: 0.93 Max: No Debt
Current: 17.46
Equity to Asset 0.68
ICAD's Equity to Asset is ranked higher than
63% of the 1764 Companies
in the Global Software - Application industry.

( Industry Median: 0.60 vs. ICAD: 0.68 )
Ranked among companies with meaningful Equity to Asset only.
ICAD' s Equity to Asset Range Over the Past 10 Years
Min: 0.25  Med: 0.69 Max: 0.92
Current: 0.68
0.25
0.92
F-Score: 2
Z-Score: -3.84
M-Score: -6.13
WACC vs ROIC
14.21%
-140.70%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -96.05
ICAD's Operating margin (%) is ranked lower than
91% of the 1810 Companies
in the Global Software - Application industry.

( Industry Median: 4.89 vs. ICAD: -96.05 )
Ranked among companies with meaningful Operating margin (%) only.
ICAD' s Operating margin (%) Range Over the Past 10 Years
Min: -129.81  Med: -13.35 Max: 12.71
Current: -96.05
-129.81
12.71
Net-margin (%) -96.37
ICAD's Net-margin (%) is ranked lower than
91% of the 1810 Companies
in the Global Software - Application industry.

( Industry Median: 3.19 vs. ICAD: -96.37 )
Ranked among companies with meaningful Net-margin (%) only.
ICAD' s Net-margin (%) Range Over the Past 10 Years
Min: -131.18  Med: -24.17 Max: 11.62
Current: -96.37
-131.18
11.62
ROE (%) -85.28
ICAD's ROE (%) is ranked lower than
92% of the 1757 Companies
in the Global Software - Application industry.

( Industry Median: 5.50 vs. ICAD: -85.28 )
Ranked among companies with meaningful ROE (%) only.
ICAD' s ROE (%) Range Over the Past 10 Years
Min: -68.8  Med: -11.17 Max: 7.57
Current: -85.28
-68.8
7.57
ROA (%) -59.23
ICAD's ROA (%) is ranked lower than
91% of the 1863 Companies
in the Global Software - Application industry.

( Industry Median: 2.73 vs. ICAD: -59.23 )
Ranked among companies with meaningful ROA (%) only.
ICAD' s ROA (%) Range Over the Past 10 Years
Min: -51.56  Med: -9.17 Max: 6.46
Current: -59.23
-51.56
6.46
ROC (Joel Greenblatt) (%) -1191.95
ICAD's ROC (Joel Greenblatt) (%) is ranked lower than
91% of the 1830 Companies
in the Global Software - Application industry.

( Industry Median: 21.22 vs. ICAD: -1191.95 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
ICAD' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -1595.88  Med: -270.07 Max: 178.33
Current: -1191.95
-1595.88
178.33
Revenue Growth (3Y)(%) 0.40
ICAD's Revenue Growth (3Y)(%) is ranked lower than
64% of the 1441 Companies
in the Global Software - Application industry.

( Industry Median: 4.90 vs. ICAD: 0.40 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
ICAD' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -27.9  Med: 0.40 Max: 31.2
Current: 0.4
-27.9
31.2
EBITDA Growth (3Y)(%) 85.30
ICAD's EBITDA Growth (3Y)(%) is ranked higher than
95% of the 1170 Companies
in the Global Software - Application industry.

( Industry Median: 7.70 vs. ICAD: 85.30 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
ICAD' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -76  Med: -21.50 Max: 217.8
Current: 85.3
-76
217.8
EPS Growth (3Y)(%) 33.60
ICAD's EPS Growth (3Y)(%) is ranked higher than
80% of the 1068 Companies
in the Global Software - Application industry.

( Industry Median: 7.50 vs. ICAD: 33.60 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
ICAD' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -72.5  Med: 1.10 Max: 59
Current: 33.6
-72.5
59
» ICAD's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-08-05)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

ICAD Guru Trades in Q2 2015

Jim Simons 452,042 sh (+48.18%)
» More
Q3 2015

ICAD Guru Trades in Q3 2015

Jim Simons 353,860 sh (-21.72%)
» More
Q4 2015

ICAD Guru Trades in Q4 2015

Jim Simons 421,099 sh (+19.00%)
» More
Q1 2016

ICAD Guru Trades in Q1 2016

Jim Simons 430,360 sh (+2.20%)
» More
» Details

Insider Trades

Latest Guru Trades with ICAD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Application Software » Software - Application
Compare:NYSE:STV, NAS:MXPT, AMEX:GSB, NAS:BSQR, NYSE:PAR, NAS:APPS, NAS:DWCH, OTCPK:MONIF, NAS:NTWK, NAS:EGAN, OTCPK:WFCF, NAS:COVS, NAS:EVOL, OTCPK:ESPAF, NAS:ARIS, NAS:PERI, OTCPK:PGQWF, NAS:MOBI, NAS:MATR, NYSE:MRIN » details
Traded in other countries:HWT1.Germany,
icad Inc is a provider of image analysis and work flow solutions that enable radiologists and other health care professionals to serve patients by identifying pathologies and pinpointing cancer earlier.

icad Inc was incorporated in the State of Delaware on February 24, 1984. The Company is a provider of image analysis and workflow solutions that enable radiologists and other healthcare professionals to serve patients by identifying pathologies and pinpointing cancer earlier. It high-performance, expandable Computer-Aided Detection (CAD) systems and workflow solutions for mammography, such as film-based, digital radiography (DR), in addition to computed radiography (CR), Magnetic Resonance Imaging (MRI), and Computed Tomography (CT). It offers a comprehensive range of high-performance upgradeable products for use with mammography, including digital radiography, computed radiography and film-based mammography. These solutions enable radiologists to serve patients by identifying pathologies and pinpointing cancers. The company's solutions aid in the early detection of the prevalent cancers including breast, prostate and colon cancer. Early detection of cancer is the key to prognosis, less invasive and lower treatment costs, and higher survival rates. The company's products are manufactured and assembled for it by a contract manufacturer of medical devices. Its manufacturing efforts are generally limited to purchasing and supply chain management, planning/scheduling, manufacturing engineering, service repairs, quality assurance, inventory management, and warehousing. Its products are sold through its direct regional sales organization in the U.S. as well as through its OEM partners, including GE Healthcare, Fuji Medical Systems, Siemens Medical, Philips Healthcare, Agfa Corporation, Sectra Medical Systems, Planmed, Fuji Medical Systems, IMS Giotto, and Carestream. The Company currently faces direct competition in its CAD business from Hologic, Inc. and imaging equipment manufacturers such as GE Healthcare, Siemens Medical, and Philips Medical Systems. The Company's systems are medical devices subject to extensive regulation by the FDA under the Federal Food, Drug, and Cosmetic Act with potentially costs for compliance.

Ratios

vs
industry
vs
history
P/B 2.84
ICAD's P/B is ranked higher than
55% of the 1976 Companies
in the Global Software - Application industry.

( Industry Median: 2.76 vs. ICAD: 2.84 )
Ranked among companies with meaningful P/B only.
ICAD' s P/B Range Over the Past 10 Years
Min: 0.43  Med: 1.63 Max: 6.59
Current: 2.84
0.43
6.59
P/S 2.52
ICAD's P/S is ranked higher than
51% of the 2022 Companies
in the Global Software - Application industry.

( Industry Median: 2.24 vs. ICAD: 2.52 )
Ranked among companies with meaningful P/S only.
ICAD' s P/S Range Over the Past 10 Years
Min: 0.77  Med: 2.51 Max: 9.26
Current: 2.52
0.77
9.26
Current Ratio 1.87
ICAD's Current Ratio is ranked lower than
52% of the 1711 Companies
in the Global Software - Application industry.

( Industry Median: 1.94 vs. ICAD: 1.87 )
Ranked among companies with meaningful Current Ratio only.
ICAD' s Current Ratio Range Over the Past 10 Years
Min: 0.57  Med: 1.85 Max: 3.85
Current: 1.87
0.57
3.85
Quick Ratio 1.51
ICAD's Quick Ratio is ranked lower than
59% of the 1711 Companies
in the Global Software - Application industry.

( Industry Median: 1.83 vs. ICAD: 1.51 )
Ranked among companies with meaningful Quick Ratio only.
ICAD' s Quick Ratio Range Over the Past 10 Years
Min: 0.44  Med: 1.22 Max: 3.33
Current: 1.51
0.44
3.33
Days Inventory 133.44
ICAD's Days Inventory is ranked lower than
90% of the 1061 Companies
in the Global Software - Application industry.

( Industry Median: 16.90 vs. ICAD: 133.44 )
Ranked among companies with meaningful Days Inventory only.
ICAD' s Days Inventory Range Over the Past 10 Years
Min: 59  Med: 99.01 Max: 265.78
Current: 133.44
59
265.78
Days Sales Outstanding 61.17
ICAD's Days Sales Outstanding is ranked higher than
58% of the 1493 Companies
in the Global Software - Application industry.

( Industry Median: 68.62 vs. ICAD: 61.17 )
Ranked among companies with meaningful Days Sales Outstanding only.
ICAD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 50.34  Med: 65.03 Max: 88.93
Current: 61.17
50.34
88.93
Days Payable 58.45
ICAD's Days Payable is ranked higher than
61% of the 1346 Companies
in the Global Software - Application industry.

( Industry Median: 43.98 vs. ICAD: 58.45 )
Ranked among companies with meaningful Days Payable only.
ICAD' s Days Payable Range Over the Past 10 Years
Min: 47.64  Med: 115.42 Max: 289.96
Current: 58.45
47.64
289.96

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 9.34
ICAD's Price/Net Current Asset Value is ranked lower than
56% of the 1360 Companies
in the Global Software - Application industry.

( Industry Median: 6.62 vs. ICAD: 9.34 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
ICAD' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 3.03  Med: 15.01 Max: 1010
Current: 9.34
3.03
1010
Price/Tangible Book 7.55
ICAD's Price/Tangible Book is ranked lower than
62% of the 1667 Companies
in the Global Software - Application industry.

( Industry Median: 4.20 vs. ICAD: 7.55 )
Ranked among companies with meaningful Price/Tangible Book only.
ICAD' s Price/Tangible Book Range Over the Past 10 Years
Min: 2.76  Med: 8.95 Max: 307.14
Current: 7.55
2.76
307.14
Price/Median PS Value 1.00
ICAD's Price/Median PS Value is ranked higher than
73% of the 1860 Companies
in the Global Software - Application industry.

( Industry Median: 1.10 vs. ICAD: 1.00 )
Ranked among companies with meaningful Price/Median PS Value only.
ICAD' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.34  Med: 1.19 Max: 8.6
Current: 1
0.34
8.6
Earnings Yield (Greenblatt) (%) -44.84
ICAD's Earnings Yield (Greenblatt) (%) is ranked lower than
95% of the 2116 Companies
in the Global Software - Application industry.

( Industry Median: 2.26 vs. ICAD: -44.84 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
ICAD' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -55.64  Med: 4.70 Max: 19.2
Current: -44.84
-55.64
19.2

More Statistics

Revenue (TTM) (Mil) $34.37
EPS (TTM) $ -2.11
Beta1.80
Short Percentage of Float0.36%
52-Week Range $2.95 - 6.23
Shares Outstanding (Mil)15.90
» More Articles for ICAD

Headlines

Articles On GuruFocus.com
Weekly CFO Buys Highlight: MCP, ICAD, BODY, VVTV, MCRI Sep 03 2012 
Weekly CFO Buys Highlight: BWEN, SGGH, ICAD, CMLS, MCP Aug 27 2012 
icad inc. Reports Operating Results (10-Q) Nov 09 2010 
icad inc. Reports Operating Results (10-Q) Aug 06 2010 
icad inc. (icad) Executive VP of Finance, CFO Darlene M Deptula-hicks sells 25,000 Shares Mar 11 2010 
icad inc. Reports Operating Results (10-Q) Aug 10 2009 
icad inc. Reports Operating Results (10-Q) May 08 2009 

More From Other Websites
ICAD INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and... Jul 28 2016
iCAD Reports Second Quarter 2016 Financial Results Jul 28 2016
iCAD Reports Second Quarter 2016 Financial Results Jul 27 2016
Q2 2016 ICAD Inc Earnings Release - After Market Close Jul 27 2016
Icade SA :ICAD-FR: Earnings Analysis: For the six months ended December 31, 2015 : July 22, 2016 Jul 22 2016
July 14, 2016 iCAD to Host Second Quarter 2016 Financial Results Conference Call on Wednesday, July... Jul 14 2016
iCAD to Host Second Quarter 2016 Financial Results Conference Call on Wednesday, July 27, 2016 Jul 14 2016
First Cervical Cancer Patient Treated in Europe with the Xoft System at Hospital Universitario... Jun 28 2016
First Cervical Cancer Patient Treated in Europe with the Xoft System at Hospital Universitario... Jun 28 2016
June 21, 2016 iCAD Commends Final USPSTF Recommendations For Colorectal Cancer Screening Including... Jun 22 2016
iCAD Commends Final USPSTF Recommendations for Colorectal Cancer Screening Including Computed... Jun 21 2016
iCAD to Present at the 6th Annual LD Micro Invitational Jun 03 2016
iCAD To Present At The LD Micro Invitational Jun 03 2016
iCAD to Participate in the 13th Annual Craig-Hallum Institutional Investor Conference Read More May 25 2016
iCAD to Participate in the 13th Annual Craig-Hallum Institutional Investor Conference May 25 2016
iCAD Announces Increased Adoption Of iReveal® Automated Breast Density Solution In U.S. May 23 2016
iCAD Announces Increased Adoption Of iReveal® Automated Breast Density Solution In U.S. May 23 2016
ICAD INC Financials May 19 2016
iCAD, Inc. :ICAD-US: Earnings Analysis: Q1, 2016 By the Numbers May 11 2016
ICAD INC Files SEC form 10-Q, Quarterly Report May 10 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)